What is the Allergy Follow-up for Children After Anaphylactic Reaction? AFCAR : Allergy Follow-up for Children After Anaphylactic Reaction

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

118 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-21

Study Completion Date

2019-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Anaphylaxis is an allergic reaction potentially fatal. The treatment is based on injection of epinephrin as soon as possible. Guidelines by the World Allergic Organisation highlight the importance of medical follow-up. This follow-up consists of an allergy consultation, the prescription and demonstration of epinephrin auto-injector and the implementation of specific measures in schools. There is no study about the recurrence of anaphylactic reaction outside the hospital.

The purpose of this study is to evaluate the allergy follow-up of children after anaphylactic reaction. The secondary objective is to evaluate the use of medical advice in case of recurrence of anaphylactic reaction.

Investigators will use a phone call questionnaire for parents of children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in the Paediatric Emergency Department in Femme-Mère-Enfant Hospital in Lyon in France. 179 children could be included in the study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Epidemiology and Management of Pediatric Anaphylaxis and Allergy in the Pediatric Emergency Department of Montpellier

NCT05112367

Anaphylaxis Allergy

UNKNOWN

Evaluation of Medical Care and Patient's Knowledge About the Behavior to Take on Secondary Prevention of Anaphylaxis

NCT03953482

Anaphylaxis

UNKNOWN

DEpth of EPinephrine Delivery With Auto-injectors Devices

NCT02886468

Anaphylactic Shock

COMPLETED NA

Self-injection and Self-management

NCT02417493

Food Allergy

COMPLETED NA

Pharmacokinetics of Intramuscular Adrenaline in Food--Allergic Teenagers

NCT03366298

Anaphylaxis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anaphylaxis Allergic Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children with anaphylactic reaction

Children who underwent an anaphylactic reaction between the 1st July 2014 and the 31st June 2016 treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France.

Phone call questionnaire

Intervention Type OTHER

Questionnaire for parents of subject about :

* the frequency of consultations with an allergist
* the information of the general practitioner or pediatrician
* the prescription of epinephrin auto-injector
* the frequency of renewal of epinephrin auto-injector
* the specialty of doctor who prescribed the renewal
* the implementation of specific measures in schools
* the frequency of renewal of specific measures in schools
* the number of recurrence of anaphylactic reaction
* the use of medical advice in case of recurrence of anaphylactic reaction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phone call questionnaire

Questionnaire for parents of subject about :

* the frequency of consultations with an allergist
* the information of the general practitioner or pediatrician
* the prescription of epinephrin auto-injector
* the frequency of renewal of epinephrin auto-injector
* the specialty of doctor who prescribed the renewal
* the implementation of specific measures in schools
* the frequency of renewal of specific measures in schools
* the number of recurrence of anaphylactic reaction
* the use of medical advice in case of recurrence of anaphylactic reaction

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age from 0 to 17
* Anaphylactic reaction meeting the criteria of Sampson et al. treated in Paediatric Emergency Department of Femme-Mère-Enfant Hospital in Lyon in France
* Anaphylactic reaction treated between the 1st July 2014 and the 31st June 2016